Skip to main
LNTH
LNTH logo

Lantheus Holdings (LNTH) Stock Forecast & Price Target

Lantheus Holdings (LNTH) Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 56%
Buy 38%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Lantheus Holdings Inc. has demonstrated robust growth with DEFINITY achieving a low-to-mid-teens increase in the second half of 2024, bolstered by a competitor's absence in the market. The company is projected to see free cash flow expansion to an estimated $550M-$600M by 2025, up from $493M in 2024, indicating strong financial health and operational efficiency. Additionally, anticipated market expansion in the diagnostic imaging sector, driven by evolving guidelines and positive clinical data, positions Lantheus for significant growth over the coming years.

Bears say

Lantheus Holdings Inc. faces a negative outlook due to decelerating growth trends, notably stemming from the expiration of Pylarify's intellectual property, which is expected to result in low-single-digit (LSD) year-over-year earnings per share (EPS) dilution in the near term. Additionally, the forecasted growth for DEFINITY is projected at low-single-digit to mid-single-digit (LSD-MSD), significantly underperforming against long-term expectations, alongside anticipated quarterly fluctuations indicating stagnation or negative growth. Moreover, the company is confronted by various risks, including increased competition in the prostate-specific membrane antigen (PSMA) PET segment, uncertainties surrounding new indications, and potential headwinds from Medicare reimbursement policies that could exacerbate pricing pressures.

Lantheus Holdings (LNTH) has been analyzed by 16 analysts, with a consensus rating of Buy. 56% of analysts recommend a Strong Buy, 38% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Lantheus Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Lantheus Holdings (LNTH) Forecast

Analysts have given Lantheus Holdings (LNTH) a Buy based on their latest research and market trends.

According to 16 analysts, Lantheus Holdings (LNTH) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $96, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $96, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Lantheus Holdings (LNTH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.